Lung cancer research gives patients hope, time with loved ones, and better quality of life. Ten years ago today, I entered a targeted therapy clinical trial for my ROS1+ lung cancer, taking an oral drug called crizotinib (trade name Xalkori). I’m still taking it (it’s now approved by the FDA and in many other countries) and have had no evidence of disease since I started it. Pretty amazing, since I had been given an expiration date of 2 years at the outside for my metastatic non-small cell lung cancer.

In honor of Lung Cancer Awareness Month, please donate to lung cancer research. The ROS1ders will be offering research grants next year! Any amount will help. https://ros1ders-inc.networkforgood.com/projects/111398-fund-ros1-cancer-research

#LCAM #LCSM